Gingival enlargement in children treated with antiepileptics

Area of Science:

• Pediatric Dentistry
• Pharmacology
• Periodontology

Background:

• Epilepsy treatment in children often involves antiepileptic drugs (AEDs).
• Certain AEDs are associated with adverse oral health effects, including gingival enlargement.
• Valproate is a commonly prescribed AED for various seizure types in pediatric populations.

Purpose of the Study:

• To investigate the prevalence, severity, and risk factors of gingival enlargement in epileptic children using valproate and other AEDs.
• To compare periodontal health between children on valproate, other AEDs, and healthy controls.
• To assess the influence of treatment duration on gingival enlargement in children receiving valproate.

Main Methods:

• A cross-sectional study involving 68 epileptic children and 50 controls.
• Data collection via questionnaires on demographics, oral hygiene, and medication history.
• Assessment of gingival enlargement, gingival index, plaque index, and probing depth using standardized measures.
• Statistical analysis using chi-square and Fisher exact tests.

Main Results:

• Both valproate and nonvalproate AED groups exhibited significantly higher rates of gingival enlargement, gingival index, plaque scores, and pocketing compared to controls (P < .001 and P < .01).
• In the valproate group, longer treatment duration correlated significantly with increased gingival enlargement (P < .001).
• Toothbrushing frequency was highest in controls, followed by the valproate group, and then the nonvalproate group (P = .000, P = .024).

Conclusions:

• Epileptic children treated with valproate face a significant risk of developing periodontal problems, particularly gingival enlargement.
• The duration of valproate therapy is a critical factor influencing the severity of gingival enlargement.
• Regular dental monitoring and improved oral hygiene practices are crucial for children on valproate therapy.